Emergent BioSolutions
EBS
#7966
Rank
โ‚น36.06 B
Marketcap
โ‚น699.04
Share price
-3.47%
Change (1 day)
5.59%
Change (1 year)

Earnings for Emergent BioSolutions (EBS)

Earnings in 2026 (TTM): โ‚น5.33 Billion

According to Emergent BioSolutions 's latest financial reports the company's current earnings are โ‚น0.64 Billion. In 2025 the company made an earning of โ‚น13.72 Billion, an increase over its 2024 earnings that were of -โ‚น6.95 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Emergent BioSolutions from 2004 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚น5.33 B-61.1%
2025 โ‚น13.72 B-297.64%
2024 -โ‚น6.95 Billion-88.82%
2023 -โ‚น62.12 Billion242.73%
2022 -โ‚น18.13 Billion-153.8%
2021 โ‚น33.68 B-20.43%
2020 โ‚น42.33 B278.02%
2019 โ‚น11.20 B27.11%
2018 โ‚น8.81 B-27.12%
2017 โ‚น12.09 B17.21%
2016 โ‚น10.31 B0.45%
2015 โ‚น10.26 B73.51%
2014 โ‚น5.91 B41.36%
2013 โ‚น4.18 B35.2%
2012 โ‚น3.09 B0.4%
2011 โ‚น3.08 B-56.46%
2010 โ‚น7.08 B76.73%
2009 โ‚น4.00 B32.94%
2008 โ‚น3.01 B-5.62%
2007 โ‚น3.19 B
2005 โ‚น4.62 B269.89%
2004 โ‚น1.25 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚น1.022 T 17,820.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น1.269 T 22,153.81%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น966.62 B 16,839.76%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
-โ‚น1.14 Billion-119.80%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
โ‚น1.99 B-65.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚น29.85 Billion-622.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น219.26 B 3,742.64%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel